Hesperos Inc.
Michael Jakob Rupar is a seasoned scientist with extensive experience in the biomedical field, currently serving as Scientist II and Multi-organ Systems Team Lead at Hesperos Inc. since March 2021, focusing on innovative experimental designs and Human-On-A-Chip technology for pharmacokinetic/pharmacodynamic studies. Previous roles include Technical Support Associate at Abbott, where expertise in rapid diagnostic equipment for SARS-CoV-2 was developed, and Molecular Laboratory Scientist at Aventus Health, specializing in laboratory specimen procedures. Michael also held administrative and instructional positions at the University of Central Florida, managing grants and leading microbiology lab sessions. Academic credentials include a Master's degree in Biomedical Sciences and a Bachelor's degree in Health Sciences from the University of Central Florida.
Hesperos Inc.
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organsystems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.